Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen, BioDiscovery to Team on CGH Analysis Tools

NEW YORK (GenomeWeb News) – Roche said today that its Roche NibleGen subsidiary has inked an alliance with Los Angeles-based BioDiscovery to offer a combination of products targeting comparative genomic hybridization.
 
The pact will combine new high-density, 2.1 million probe arrays from Roche NimbleGen with BioDiscovery’s Nexus Copy Number software foe use in whole-genome CGH analysis. Under the alliance, the firms will co-market and co-promote their products and services to scientists worldwide.
 
In addition, Roche NimbleGen said that the firm would present data generated from the arrays using Nexus software to researchers through a series of seminars.
 
Terms of the alliance were not disclosed.
 

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.